|
Subject Characteristics |
||||||
| Group |
Sex |
Age |
PC20 |
FEV1(%) |
Atopy |
Medication |
|
|
||||||
| Asthmatic |
M |
24 |
2.33 |
4.03 (98) |
Yes |
β-agonist only |
| Asthmatic |
F |
20 |
4.21 |
3.51 (105) |
Yes |
β-agonist only |
| Asthmatic |
M |
20 |
2 |
4.22 (98) |
Yes |
β-agonist only |
| Asthmatic |
F |
18 |
0.56 |
3.09 (36) |
Yes |
β-agonist only |
| Asthmatic |
M |
18 |
0.66 |
4.29 (94) |
Yes |
β-agonist only |
| Asthmatic |
F |
22 |
0.14 |
3.55 (93) |
Yes |
β-agonist only |
| Asthmatic |
M |
26 |
saline |
3.77 (82) |
Yes |
β-agonist only |
| Asthmatic |
M |
26 |
3.11 |
4.00 (76.7) |
Yes |
β-agonist only |
| Mean |
21.8 ± 3.3 |
1.9 ± 1.5 |
3.8 ± 0.4 |
|||
|
|
||||||
| Normal |
M |
32 |
> 128 |
3.76 (94) |
No |
No |
| Normal |
F |
38 |
> 128 |
3.27 (n/a) |
No |
No |
| Normal |
M |
23 |
> 128 |
n/a |
No |
No |
| Normal |
M |
50 |
> 256 |
4 (80) |
No |
No |
| Normal |
M |
32 |
25.5 |
4.01 (122) |
No |
No |
| Normal |
F |
26 |
96 |
2.93 (95) |
No |
No |
| Normal |
M |
29 |
17.7 |
3.82 (89) |
No |
No |
| Normal |
M |
23 |
> 128 |
5.06 (103) |
No |
No |
| Mean |
31.6 ± 9.0 |
3.8 ± 0.7 |
||||
|
PC20: provocative concentration of methacholine to cause a fall in FEV1 of 20%; FEV1: forced expiratory volume in 1 second; % predicted is shown in parentheses; M, male; F, female; n/a, not available | ||||||
Le Bellego et al. Respiratory Research 2006 7:68 doi:10.1186/1465-9921-7-68 |
||||||